Awuah Kwabena T, Gorban-Brennan Nancy, Yalamanchili Hima Bindu, Finkelstein Fredric O
Yale New Haven Hospital, New Haven, Connecticut, USA.
Renal Research Institute, New Haven, Connecticut, USA.
Adv Perit Dial. 2013;29:1-3.
Patients with end-stage renal disease treated with peritoneal dialysis (PD) are often put on standard one size fits all" regimens, despite having varying degrees of residual renal function (RRF). The present study reports our experience with initiation of PD using 2 icodextrin exchanges daily in patients with RRF corresponding to a weekly Kt/Vurea of at least 1.0. Peritoneal and RRF Kt/Vurea were tracked closely, and total Kt/Vurea was maintained between 1.7 and 2.0. One patient developed a rash and was changed to 3 dextrose exchanges daily. All patients were satisfied with their treatment regimen, and no other adverse events or symptoms were reported.